SIMULPHARMA ApS: Financial statements 2024
CVR: 32832075
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SIMULPHARMA ApS (CVR 32832075) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. That is an increase of 38.2% compared with the year before. The profit margin was 26%. Equity in the 2024 report amounted to DKK 63,769. The solvency ratio was 83.5%.
- Revenue
- DKK 158,958
- Gross Profit
- DKK 41,196
- Profit/Loss
- DKK 41,292
- Equity
- DKK 63,769
- Total Assets
- DKK 76,394
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 159K | 41K | 41K | 64K | - |
| 2023 | 115K | 115K | -57K | 22K | 1 |
| 2022 | 484K | 406K | -58K | 80K | 1 |
| 2021 | 636K | 636K | -83K | 138K | 1 |
| 2020 | 719K | 719K | 36K | 221K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
SIMULPHARMA ApS has published its annual report for 2023. Revenue came to DKK 114,981, and the net result was DKK -57,341.
About SIMULPHARMA ApS
SIMULPHARMA ApS was a Danish company of the type Anpartsselskab based in Birkerød, founded in 2010. The company has been dissolved on 24 August 2026. The company was registered under the industry Engroshandel med andre maskiner og andet udstyr. The company has 1 employee (2025). In 2024, the company reported revenue of DKK 158,958 and a net result of DKK 41,292 compared with DKK -57,341 the year before. Equity in the 2024 report amounted to DKK 63,769.